期刊文献+

钙剂联合阿法骨化醇治疗绝经后妇女骨质疏松的临床分析

Calcium Supplements Sombined afar Calciferol Clinical Analysis for the Treatment of Postmenopausal Osteoporosis
下载PDF
导出
摘要 目的研究钙剂联合阿法骨化醇治疗绝经后妇女骨质疏松的临床效果。方法选取该院2016年8月—2017年1月收治的100例绝经后妇女骨质疏松患者为研究对象,将其分为两组,对照组患者单独采用钙剂进行治疗,观察组患者联合应用钙剂和阿法骨化醇进行治疗,对比两组临床疗效。结果相对于治疗前,两组患者治疗后的血清TNF-a、IL-6、腰椎侧位(L2-4)BMD、BMD水平均在一定程度上得到改善,并且观察组显著优于对照组;观察组患者的临床治疗总有效率为96.00%,显著高于对照组的80.00%(P<0.05)。 Objective to study the calcium supplements combined afar calciferol clinical effect for the treatment of postmenopausal osteoporosis.Methods From August 2016 to January 2017 were 100 patients with postmenopausal osteoporosis as the research object,it can be divided into two groups,control group patients with single treatment with calcium supplements,and observation group of patients with combined use of calcium supplements and afar calciferol treatment,compared two groups of clinical curative effect.Results Compared with before treatment and after treatment in both groups of serum TNF-a,IL-6,lumbar lateral position(L2-4) BMD,BMD level are improved to some extent,and the observation group was significantly better than the control group;Observation group of patients with clinical treatment the total effective rate was 96.00%,significandy higher than that of control group 80.00%(P < 0.05).Conclusion Calcium supplements combined afar calciferol treatment of postmenopausal osteoporosis clinical effect is remarkable,is worth popularizing widely in clinic.
出处 《双足与保健》 2017年第7期20-21,24,共3页 Biped and Health
关键词 钙剂 阿法骨化醇 绝经后妇女骨质疏松 临床效果 Calcium supplements Afar ossification alcohol Postmenopausal osteoporosis Clinical effect
  • 相关文献

参考文献4

二级参考文献26

  • 1何勇,刘树琴,王长江,贾敬华,王佑民,章秋,潘天荣.IL-6、TNF-α在绝经后骨质疏松症发生中的作用[J].中国临床保健杂志,2007,10(1):41-43. 被引量:19
  • 2Freitas-Neto CA,De Oliveira Fagundes WB,Ribeiro M Jr,et al.Unilateral Uveitis with Vitreous Haze Follow ing Zoledronic Acid Therapy for Osteoporosis[J].Semin Ophthalmol,2013,22(29):68-80.
  • 3Kachnic LA,Pugh SL,Tai P,et al.randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients[J].Prostate Cancer Prostatic Dis,2013,16(4):382-386.
  • 4Rossini M,Zanotti R,Viapiana O,et al.Zoledronic Acid in Osteoporosis Secondary to M astocytosis[J].Am J M ed,2014,3(19):9340-9343.
  • 5Spiegel R,Nawroth PP,Kasperk C.The effect of zoledronic acid on the fracture risk in men with osteoporosis[J].J Endocrinol Invest,2014,37(3):229-232.
  • 6Khajuria DK,Razdan R,Mahapatra DR.The combination therapy with zoledronic acid and propranolol improves the trabecular microarchitecture and mechanical property in an rat model of postmenopausal osteoporosis[J].J Osteoporos,2014,22(30):56-60.
  • 7迟晓星,张涛,崔洪斌.大豆异黄酮对更年期妇女骨密度影响[J].中国公共卫生,2008,24(2):163-164. 被引量:20
  • 8张华,陈敢峰,吴俊哲,陈燕娴.绝经后骨质疏松症血清中Leptin、NO、IL-6 BGP及E_2的检测意义[J].中国中医骨伤科杂志,2008,16(2):1-3. 被引量:15
  • 9骨质疏松骨折诊疗指南[J].中华骨科杂志,2008,28(10):875-878. 被引量:161
  • 10张伟滨.骨质疏松性骨折[J].中国医师进修杂志(外科版),2009,32(2):1-3. 被引量:5

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部